Comorbidities in Type 2 Diabetes Mellitus

NARecruitingINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

December 30, 2025

Study Completion Date

August 30, 2026

Conditions
Type 2 Diabetes
Interventions
DIAGNOSTIC_TEST

HBA1C

blood sample on EDTA

DIAGNOSTIC_TEST

Lipid profile, including total, LDL, and HDL cholesterol and Triglycerides

serum sample

DIAGNOSTIC_TEST

Urine analysis and urinary albumin-to-creatinine ratio

Morning urine sample

DIAGNOSTIC_TEST

Serum creatinine and estimated glomerular filtration rate

serum sample

DIAGNOSTIC_TEST

Complete blood count

blood sample on EDTA

DIAGNOSTIC_TEST

Thyroid-stimulating hormone

serum sample

DIAGNOSTIC_TEST

Serum iron, TIBC, Transferrin saturation and serum ferritin if needed

serum sample

PROCEDURE

Electrocardiography (ECG)

by electrocardiogram

PROCEDURE

Transthoracic echocardiography, Neck ultrasonography if needed and abdominopelvic ultrasound

imaging

PROCEDURE

Arterial duplex ultrasound of both lower limbs

imaging

DIAGNOSTIC_TEST

Random blood glucose

serum sample

DIAGNOSTIC_TEST

AST, ALT, albumin

serum sample

Trial Locations (1)

72511

RECRUITING

New Valley University, Al Khārjah

All Listed Sponsors
lead

New Valley University

OTHER